Name | procainamide hydrochloride |
Synonyms | PROCAINAMIDE HCL procainamide HCl PROCAINAMIDE HYDROCHLORIDE procainamide hydrochloride Procainamidi Hydrochloridum PROCAINE AMIDE HYDROCHLORIDE 4-AMINO-N-[2'-(DIETHYLAMINO)ETHYL]BENZAMIDE HCL 4-AMINO-N-(2-DIETHYLAMINOETHYL)BENZAMIDE HYDROCHLORIDE N-(2-DIETHYLAMINOETHYL)-4-AMINOBENZAMIDE HYDROCHLORIDE 4-amino-n-(2-diethylaminoethyl)benzamide hydrochloride 2-[[(4-aminophenyl)-oxomethyl]amino]ethyl-diethylammonium 4-AMINOBENZOIC ACID 2-DIETHYLAMINOETHYLAMIDE HYDROCHLORIDE |
CAS | 614-39-1 |
EINECS | 210-381-7 |
InChI | InChI=1/C13H21N3O.2ClH/c1-3-16(4-2)10-9-15-13(17)11-5-7-12(14)8-6-11;;/h5-8H,3-4,9-10,14H2,1-2H3,(H,15,17);2*1H |
Molecular Formula | C13H22ClN3O |
Molar Mass | 271.79 |
Density | 1.2027 (rough estimate) |
Melting Point | 165-168°C |
Water Solubility | soluble |
Solubility | H2O: soluble1g/10 mL, clear, greenish-yellow |
Appearance | Powder |
Color | White to slightly yellow |
Merck | 13,7845 |
BRN | 3729517 |
Storage Condition | 2-8°C |
Sensitive | Light Sensitive/Air Sensitive |
Refractive Index | 1.6330 (estimate) |
Physical and Chemical Properties | Melting point 165-170°C water-soluble soluble |
Use | Antiarrhythmic drugs, suitable for ventricular arrhythmias |
Hazard Symbols | Xn - Harmful |
Risk Codes | R22 - Harmful if swallowed R36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S37/39 - Wear suitable gloves and eye/face protection |
WGK Germany | 3 |
RTECS | CV2295000 |
HS Code | 29242990 |
This product is N-[(2-diethylamino) ethyl]-4-aminobenzamide hydrochloride. The content of C13H21N30 • HCl shall not be less than 99.0% calculated on a dry basis.
The melting point of this product (General 0612) is 165~169 ℃.
take l.Og of this product, Add 10ml of water to dissolve, and measure it according to law (General rule 0631). The pH value should be 5.0~6.5.
take this product, dry to constant weight at 105 ℃, weight loss shall not exceed 0.3% (General rule 0831).
take l.Og of this product and check it according to law (General rule 0841). The residue left shall not exceed 0.1%.
The residue left under the item of taking the ignition residue shall not contain more than 10 parts per million of heavy metal when examined by law (General Principles 0821, Law II).
take this product about 0.55g, precision weighing, according to the permanent stop titration method (General 0701), with sodium nitrite titration solution (0.lmol/L) titration. Each 1 ml of sodium nitrite titration solution (0.1 mol/L) corresponds to 27.18mg of C13H21N30. Hc1.
local anesthetic.
light shielding, sealed storage.
This product contains procainamide hydrochloride (C13H21N30 • HC1) should be the label amount of 95.0% ~ 105.0%.
This product is white to yellowish or sugar-coated.
Take 10 tablets of this product, put it in a 100ml measuring flask, add 50ml of water, shake to dissolve the hydrochloric acid, dilute to the scale with water, shake, stand, take 20ml of supernatant, according to the permanent stop titration method (General rule 0701), with sodium nitrite titration solution (0.lmol /L titration. Each 1 ml of sodium nitrite titration solution (0.1 mol/L) corresponds to 27.18mg of C13H21N30. HCI.
Same as procainamide hydrochloride.
0.25g
light shielding, sealed storage.
This product is a sterilized aqueous solution of procainine hydrochloride. The content of procainine hydrochloride (C13H21N30 • HC1) shall be between 95.0% and 105.0% of the labeled amount.
This product is a clear colorless liquid.
take 5ml of this product accurately, add 40ml of water and 10ml of hydrochloric acid solution (1-2), quickly boil, immediately cool to room temperature, follow the permanent stop titration method (General rule 0701), with sodium nitrite titration solution (0.lmol/L) titration. Each 1 ml of sodium nitrite titration solution (0.1 mol/L) corresponds to 27.18mg of C13H21N30. Hc1.
Same as procainamide hydrochloride.
(l )lml:0.1g ( 2) 2ml: 0.2g (3)5ml:0.5g(4) 10ml:lg
light shielding, closed storage.
EPA chemical substance information | information provided by: ofmpeb.epa.gov (external link) |
Overview | procainamide hydrochloride is a chemical drug substance that is similar to quinidine and is a typical membrane stabilizer for ventricular arrhythmias, it can also be used to prevent arrhythmia in patients with atrial arrhythmia and myocardial infarction. |
Use | procainamide hydrochloride is a Class I a antiarrhythmic drug. It can prolong the atrial refractory period, reduce the atrioventricular conductivity and myocardial automaticity, but the inhibition of myocardial contractility is weaker than that of quinidine. It is suitable for paroxysmal tachycardia, frequent premature beats (good for ventricular premature beats), atrial fibrillation and atrial flutter, and is often used alternately with quinidine. |
preparation | procainamide was originally synthesized using 4-nitrobenzoyl chloride as the starting material, in the following decades, many new synthetic methods appeared, such as 4-nitrobenzoic acid and diethylaminoethylamine as starting materials. However, the yield of these synthetic routes is low, and the product is difficult to purify, which leads to industrial difficulties in production and is difficult to apply to large-scale industrial production. |
Use | antiarrhythmic. Similar to quinidine, it is a typical membrane stabilizer. It is suitable for ventricular arrhythmia, atrial arrhythmia and prevention of arrhythmia in patients with myocardial infarction. antiarrhythmic drug, suitable for ventricular arrhythmia |
production method | p-nitrobenzoyl chloride is condensed with diethylaminoethylamine to give P-nitro-N-(2-diethylaminoethyl) benzamide (nitrocarinamine), and then the catalytic hydrogenation of procaine Amine, and then using hydrochloric acid to salt is the goods. |